Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adrenocortical carcinoma: Impact of surgical treatment.
Mirallié E, Blanchard C, Caillard C, Rodien P, Briet C, Mucci S, Drui D, Hamy A. Mirallié E, et al. Among authors: drui d. Ann Endocrinol (Paris). 2019 Nov;80(5-6):308-313. doi: 10.1016/j.ando.2019.09.001. Epub 2019 Oct 18. Ann Endocrinol (Paris). 2019. PMID: 31722787 Review.
Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial.
Gadelha MR, Bronstein MD, Brue T, Coculescu M, Fleseriu M, Guitelman M, Pronin V, Raverot G, Shimon I, Lievre KK, Fleck J, Aout M, Pedroncelli AM, Colao A; Pasireotide C2402 Study Group. Gadelha MR, et al. Lancet Diabetes Endocrinol. 2014 Nov;2(11):875-84. doi: 10.1016/S2213-8587(14)70169-X. Epub 2014 Sep 24. Lancet Diabetes Endocrinol. 2014. PMID: 25260838 Clinical Trial.
18F-FDG PET/CT in the characterization and surgical decision concerning adrenal masses: a prospective multicentre evaluation.
Ansquer C, Scigliano S, Mirallié E, Taïeb D, Brunaud L, Sebag F, Leux C, Drui D, Dupas B, Renaudin K, Kraeber-Bodéré F. Ansquer C, et al. Among authors: drui d. Eur J Nucl Med Mol Imaging. 2010 Aug;37(9):1669-78. doi: 10.1007/s00259-010-1471-8. Epub 2010 May 19. Eur J Nucl Med Mol Imaging. 2010. PMID: 20490488 Clinical Trial.
Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC).
Kraeber-Bodéré F, Salaun PY, Ansquer C, Drui D, Mirallié E, Faivre-Chauvet A, Barbet J, Goldenberg DM, Chatal JF. Kraeber-Bodéré F, et al. Among authors: drui d. Tumour Biol. 2012 Jun;33(3):601-6. doi: 10.1007/s13277-012-0359-6. Epub 2012 Mar 7. Tumour Biol. 2012. PMID: 22396039
Pheochromocytoma revealed by acute heart failure. When should we operate? Presented at the ESES Congress, Gothenburg May 25-26, 2012.
Müller G, Saint F, Hamy A, Lifante JC, Carnaille B, Sebag F, Ménégaux F, Vandwalle J, Drui D, Caillard C, Rodien P, Roy M, Peix JL, Pattou F, Brunaud L, Henry JF, Mirallié E. Müller G, et al. Among authors: drui d. Langenbecks Arch Surg. 2013 Jun;398(5):729-33. doi: 10.1007/s00423-012-1040-7. Epub 2012 Dec 19. Langenbecks Arch Surg. 2013. PMID: 23250652
Surgery for 'asymptomatic' mild primary hyperparathyroidism improves some clinical symptoms postoperatively.
Blanchard C, Mathonnet M, Sebag F, Caillard C, Hamy A, Volteau C, Heymann MF, Wyart V, Drui D, Roy M, Cariou B, Archambeaud F, Rodien P, Henry JF, Zarnegar R, Hardouin JB, Mirallié E. Blanchard C, et al. Among authors: drui d. Eur J Endocrinol. 2013 Oct 3;169(5):665-72. doi: 10.1530/EJE-13-0502. Print 2013 Nov. Eur J Endocrinol. 2013. PMID: 23956299 Clinical Trial.
¹⁸F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma.
Salaun PY, Campion L, Ansquer C, Frampas E, Mathieu C, Robin P, Bournaud C, Vuillez JP, Taieb D, Rousseau C, Drui D, Mirallié E, Borson-Chazot F, Goldenberg DM, Chatal JF, Barbet J, Kraeber-Bodéré F. Salaun PY, et al. Among authors: drui d. Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1501-10. doi: 10.1007/s00259-014-2772-0. Epub 2014 May 8. Eur J Nucl Med Mol Imaging. 2014. PMID: 24806110 Clinical Trial.
95 results